Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

Estrogen receptor-negative Hs578T human breast cancer cells secrete insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 as major binding protein (BP) species. Our previous immunohistochemical studies (Oh, Y., Müller, H. L., Pham, H., Lamson, G., and Rosenfeld, R. G. (1992) Endocrinology 131, 3123-3125) have demonstrated the existence of cell surface-associated IGFBP-3 and release of cell surface-associated IGFBP-3 into conditioned media by addition of IGF peptide in Hs578T cells. In this study, we have demonstrated that IGFBP-3 binding on the cell surface is specific and receptor-mediated, by showing: 1) a dose-dependent increase of IGFBP-3 binding by addition of divalent cations (CaCl2 and MnCl2); 2) dose-dependent competition of 125I-IGFBP-3E. coli by unlabeled IGFBP-3E.coli (> 80% competition at 100 nM), but not by IGFBP-1 or fibronectin. In addition, exogenous IGFBP-3 treatment resulted in a significant inhibitory effect on monolayer growth of Hs578T cells. This inhibitory effect of IGFBP-3 was shown to be specific and IGF-independent by demonstrating: 1) dose-dependent inhibition on cell growth (60% inhibition at 20 nM) and inhibition on DNA synthesis (10 nM; p < 0.05, 20 nM; p < 0.005) by exogenous IGFBP-3E. coli, but not by IGFBP-1; 2) absence of stimulatory effects on monolayer cell growth by either native IGFs or IGF analogs which have significantly decreased affinity for IGFBPs, but retain full affinity for type 1 and 2 IGF receptors; 3) significant diminution of the IGFBP-3 inhibitory effects on monolayer growth by coincubation with native IGFs, but not by coincubation with IGF analogs with decreased affinity for IGFBP-3. In conclusion, exogenous IGFBP-3 shows specific binding on the cell surface and can inhibit Hs578T cell monolayer growth by itself, suggesting the existence of specific membrane-associated proteins or receptors for IGFBP-3. Furthermore, IGF-I and -II can attenuate inhibitory effect of IGFBP-3 by forming IGF.IGFBP-3 complexes, thereby preventing cell surface binding of IGFBP-3.

• Publication year

  1993

• Venue

  Journal of Biological Chemistry

• Publication date

  1993-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/s0021-9258(18)82426-7PMID 7686909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated.

  1993cited by this paper
• Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth.

  1993cited by this paper
• 1,25-Dihydroxyvitamin D3 stimulates the secretion of insulin-like growth factor binding protein 3 (IGFBP-3) by cultured human osteosarcoma cells.

  1992cited by this paper
• Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms.

  1992cited by this paper
• The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells.

  1992cited by this paper
• Interaction between the p21ras GTPase activating protein and the insulin receptor.

  1992cited by this paper
• Mechanisms of Sertoli cell insulin-like growth factor (IGF)-binding protein-3 regulation by IGF-I and adenosine 3',5'-monophosphate.

  1992cited by this paper
• Insulin‐like growth factor binding protein (IGFBP‐3), an inhibitor of serum growth factors other than IGF‐I and ‐II

  1992cited by this paper
• Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells.

  1992cited by this paper
• Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion.

  1992cited by this paper
• Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma.

  1992cited by this paper
• Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells.

  1992cited by this paper
• Regulation of insulin-like growth factor-binding protein expression by thyroid hormone in rat GH3 pituitary tumor cells.

  1992cited by this paper
• Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.

  1992cited by this paper
• Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins.

  1991cited by this paper
• Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts.

  1991cited by this paper
• Isolation and molecular cloning of insulin-like growth factor-binding protein-6.

  1991cited by this paper
• Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human.

  1991cited by this paper
• Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation.

  1991cited by this paper
• Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

  1991cited by this paper
• [Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experiments.

  1991cited by this paper
• Presence of IDF45 (mlGFBP-3) binding sites on chick embryo fibroblasts.

  1991cited by this paper
• Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.

  1991cited by this paper
• Regulators and effectors of ras proteins.

  1991cited by this paper
• An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranes.

  1990cited by this paper
• The GTPase superfamily: a conserved switch for diverse cell functions

  1990cited by this paper
• Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases

  1990cited by this paper
• Binding of human syndecan to extracellular matrix proteins.

  1990cited by this paper
• Characterization of insulin-like growth factor-binding proteins in human serum from patients with chronic renal failure.

  1990cited by this paper
• Insulin-like growth factor binding protein-3 secretion from cultured rat sertoli cells: dual regulation by follicle stimulating hormone and insulin-like growth factor-I.

  1990cited by this paper
• Differences in inhibition by IDF45 (an inhibitory diffusible factor) of early RNA synthesis stimulation induced by pp60 v‐src and various mitogens

  1990cited by this paper
• Production of insulin-like growth factor binding proteins (IGFBPs) by porcine granulosa cells: identification of IGFBP-2 and -3 and regulation by hormones and growth factors.

  1990cited by this paper
• Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation.

  1990cited by this paper
• Regulation of insulin-like growth factor (IGF)-binding protein synthesis by insulin and IGF-I in cultured bovine fibroblasts.

  1990cited by this paper
• Insulin-like growth factor binding proteins in human breast cancer cells: relationship to hIGFBP-2 and hIGFBP-3.

  1990cited by this paper
• Structural and biological characterization of bovine insulin-like growth factor binding protein-3.

  1990cited by this paper
• Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status.

  1990cited by this paper
• Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2).

  1989cited by this paper
• Characterization of insulin-like growth factor-binding proteins from sheep thyroid cells.

  1989cited by this paper
• Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.

  1989cited by this paper
• Expression of two insulin-like growth factor-binding proteins in a human endometrial cancer cell line: structural, immunological, and genetic characterization.

  1989cited by this paper
• The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor.

  1989cited by this paper
• Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation.

  1989cited by this paper
• Signal transmission by the insulin-like growth factors.

  1989cited by this paper
• Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

  1989cited by this paper
• Production of carrier proteins for insulin‐like growth factors (IGFs) by rat osteoblastic cells Regulation by IGF I and cortisol

  1989cited by this paper
• Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids.

  1989cited by this paper
• Characterization of insulin-like growth factor binding proteins from human breast cancer cells.

  1989cited by this paper
• Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein.

  1988cited by this paper
• Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts.

  1988cited by this paper
• Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph.

  1988cited by this paper
• Structure of the receptor for insulin-like growth factor II: the puzzle amplified.

  1988cited by this paper
• Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs.

  1988cited by this paper
• Isolation and characterization of a cDNA encoding the low molecular weight insulin‐like growth factor binding protein (IBP‐1).

  1988cited by this paper
• Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.

  1988cited by this paper
• Induction of fibroblast spreading by Mn2+: a possible role for unusual binding sites for divalent cations in receptors for proteins containing Arg-Gly-Asp.

  1988cited by this paper
• Cloning, characterization, and expression of a human insulin-like growth factor binding protein.

  1988cited by this paper
• Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions.

  1988cited by this paper
• Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells.

  1988cited by this paper
• Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

  1987cited by this paper
• Insulin-like growth factor II increases cytoplasmic free calcium in competent Balb/c 3T3 cells treated with epidermal growth factor.

  1987cited by this paper
• An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

  1987cited by this paper
• Effect of an anti-insulin-like growth factor I receptor antibody on insulin-like growth factor II stimulation of DNA synthesis in human fibroblasts.

  1986cited by this paper
• Identification of an insulin‐like growth factor‐binding protein in human cerebrospinal fluid with a selective affinity for IGF‐II

  1986cited by this paper
• Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.

  1986cited by this paper
• Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media.

  1986cited by this paper
• Purification of the insulin-like growth factor II (IGF-II) receptor from an IGF-II-producing cell line, and generation of an antibody which both immunoprecipitates and blocks the type 2 IGF receptor.

  1986cited by this paper
• A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient.

  1984cited by this paper
• Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.

  1984cited by this paper
• Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition.

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities

  2024cites this paper
• Turkish coffee has an antitumor effect on breast cancer cells in vitro and in vivo

  2024cites this paper
• Histone deacetylase 9-mediated phenotypic transformation of vascular smooth muscle cells is a potential target for treating aortic aneurysm/dissection.

  2024cites this paper
• Insulin-like growth factor binding protein-3 induces senescence by inhibiting telomerase activity in MCF-7 breast cancer cells

  2023cites this paper
• Insulin-like Growth Factor-I Biocompartmentalization Across Blood, Interstitial Fluid and Muscle, Before and After 3 Months of Chronic Resistance Exercise.

  2022cites this paper
• Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer

  2020cites this paper
• Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell

  2020cites this paper
• Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling

  2020cites this paper
• IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer

  2020cites this paper
• Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease

  2020cites this paper
• Role of Insulin-Like Growth Factor Binding Protein-3 in the Pathogenesis of Herpes Stromal Keratitis

  2020cites this paper
• Human Wharton's Jelly Mesenchymal Stem Cells Show Unique Gene Expression Compared with Bone Marrow Mesenchymal Stem Cells Using Single-Cell RNA-Sequencing

  2019cites this paper
• Lycopene and Down-regulation of Cyclin D1, pAKT and pBad

  2019cites this paper
• In Vitro Anticancer Activities of B6 Vitamers: A Mini-review

  2019cites this paper
• Contrasting effects of IGF binding protein‐3 expression in mammary tumor cells and the tumor microenvironment

  2019cites this paper
• Understanding towards the biophysical interaction of polymeric proanthocyanidins (persimmon condensed tannins) with bio-membranes: Relevance for biological effects.

  2019cites this paper
• IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?

  2018cites this paper
• Expression of kit ligand and insulin-like growth factor binding protein 3 during in vivo or in vitro development of ovarian follicles in sheep.

  2017cites this paper
• Special Issue: Cancer Metabolism

  2017cites this paper
• Insulin-like growth factor binding protein 3 inhibits inflammatory response and promotes apoptosis in fibroblast-like synoviocytes of osteoarthritis

  2017cites this paper
• Role of Growth Factor Signaling in Cancer

  2016cites this paper
• airway smooth muscle cells 1-induced cell growth in human β IGFBP-3 mediates TGF-

  2016cites this paper
• Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma.

  2016cites this paper
• GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.

  2016cites this paper
• Altération du phénotype chondrocytaire : Rôle de l’homéostasie locale de facteurs modulant la balance Pi/Ppi

  2016cites this paper
• regulator of osteoblast cell proliferation interacting protein: evidence IGFBP5-IP is a potential Identification and characterization of novel IGFBP5

  2016cites this paper
• IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses

  2016cites this paper
• Growth suppression and cell death by pyridoxal is dependent on p53 in the human breast cancer cell line MCF-7

  2015cites this paper
• Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?

  2015cites this paper
• Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression

  2015cites this paper
• The Importance of the Insulin-like Growth Factor Signaling Pathway in Lung Cancer and the Potential of its Components as Therapeutic Targets

  2015cites this paper
• Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage

  2015cites this paper
• Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells

  2015cites this paper
• Implication for the regulation of catabolism drawn from the single insulin-like growth factor binding domain protein (SIBD) gene in the mud crab, Scylla paramamosain.

  2015cites this paper
• IGFBP 3 polymorphisms and risk of esophageal cancer in a Chinese population

  2015cites this paper
• IGFBP3 polymorphisms and risk of esophageal cancer in a Chinese population.

  2015cites this paper
• Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer.

  2015cites this paper
• Disorders of growth hormone/insulin-like growth factor secretion and action

  2014cites this paper
• Antiangiogenic and proteolytic activities of prostate-specific antigen

  2014cites this paper
• CC chemokine ligand 18 and IGF-binding protein 6 as potential serum biomarkers for prostate cancer.

  2014cites this paper
• Single nucleotide polymorphism in Egyptian cattle insulin-like growth factor binding protein-3 gene

  2014cites this paper
• Regulation of Apoptosis and Inflammatory Responses by Insulin‐like Growth Factor Binding Protein 3 in Fibroblast‐like Synoviocytes and Experimental Animal Models of Rheumatoid Arthritis

  2014cites this paper
• A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules

  2014cites this paper
• IGFBP-3: a cell fate pivot in cancer and disease.

  2014cites this paper
• Dissection of a novel autocrine signaling pathway via quantitative secretome and interactome mapping.

  2014cites this paper
• IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer

  2013cites this paper
• Insulin-Like Growth Factor Binding Proteins Increase Intracellular Calcium Levels in Two Different Cell Lines

  2013influential citation
• IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis

  2013cites this paper
• Role of Insulin-Like Growth Factor Binding Protein-3 in 1, 25-Dihydroxyvitamin-D3-Induced Breast Cancer Cell Apoptosis

  2013cites this paper
• Independence in Prostate Cancer Models Activity and Accelerates Progression to Androgen Binding Protein-5 Potentiates Insulin-like Growth Factor-I Castration-induced Up-Regulation of Insulin-like Growth Factor

  2013cites this paper
• Role of insulin-like growth factor binding protein-3 in glucose and lipid metabolism

  2013cites this paper
• The Contributions of HIF-Target Genes to Tumor Growth in RCC

  2013cites this paper
• The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities

  2012cites this paper
• Variability of the paracrine‐induced osteoclastogenesis by human breast cancer cell lines

  2012cites this paper
• Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents.

  2012cites this paper
• Impact of IGF system on dietary short chain fatty a cid-induced anti- inflammatory and anti-tumor effects.

  2012cites this paper
• Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma

  2012cites this paper
• Normal and Aberrant Growth

  2011cites this paper
• IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells.

  2011cites this paper
• Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events.

  2011cites this paper
• Insulin-like Growth Factor-binding Protein-3 (IGFBP-3) Blocks the Effects of Asthma by Negatively Regulating NF-κB Signaling through IGFBP-3R-mediated Activation of Caspases*♦

  2011cites this paper
• The Effect of IGFBP-3 on Adipokines and Gene Expression in Differentiated 3T3-L1 Adipocytes

  2011cites this paper
• Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.

  2011cites this paper
• Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

  2011cites this paper
• IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells.

  2011cites this paper
• Role of Central Insulin-Like Growth Factor-1 Receptor Signalling in Ageing and Endocrine Regulation

  2011cites this paper
• Targeting IGF-I, IGFBPs and IGF-I receptor system in cancer: the current and future in breast cancer therapy.

  2011cites this paper
• Association Between Insulin-Like Growth Factor Binding Protein-3 Promoter Polymorphism of −1590 C>A and Lung Cancer Susceptibility in a Chinese Han Population

  2011cites this paper
• Correlation between the Expression Reduction of Insulin-like Growth Factor Binding Protein (IGFBP)-3 and PTEN and the Clinicopathological Parameters in Breast Cancer

  2010cites this paper
• Mining of serum glycoproteins by an indirect approach using cell line secretome

  2010cites this paper
• Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.

  2010cites this paper
• Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?

  2010cites this paper
• Hepatic Gene Networks in Morbidly Obese Patients With Nonalcoholic Fatty Liver Disease

  2010cites this paper
• Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer*

  2010cites this paper
• Functional modulation of IGF-binding protein-3 expression in melanoma.

  2010cites this paper
• Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells

  2009influential citation
• Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanisms

  2009cites this paper
• Insulin resistance and hyperinsulinaemia in the development and progression of cancer

  2009cites this paper
• The expression and function of IGFBP-3 in normal and malignant breast tissue.

  2009cites this paper
• Unraveling insulin-like growth factor binding protein-3 actions in human disease.

  2009cites this paper
• Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity*

  2009cites this paper
• c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.

  2009cites this paper
• Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.

  2009cites this paper
• Insulin-like Growth Factor Binding Protein-3 Induces G1 Cell Cycle Arrest with Inhibition of Cyclin-dependent Kinase 2 and 4 in MCF-7 Human Breast Cancer Cells

  2009cites this paper
• Perspectives in mammalian IGFBP-3 biology: local vs. systemic action.

  2009cites this paper
• IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis.

  2008cites this paper
• Molecular regulation of insulin-like growth factor binding protein-3 and its role in ribotoxic stress-induced apoptosis

  2008cites this paper
• Colostrum supplementation restores insulin-like growth factor -1 levels and alters muscle morphology following massive small bowel resection.

  2008cites this paper
• A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import.

  2008cites this paper
• In contrast to lung fibroblasts--no signs of senescence in skin fibroblasts of patients with emphysema.

  2008cites this paper
• INFLUENCE OF ALCOHOL ON SOME APPETITE- REGULATING HORMONES IN MAN

  2008cites this paper
• An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner.

  2008cites this paper
• IGFBP3 mRNA expression in benign and malignant breast tumors

  2007cites this paper
• A 30-kDa fragment of insulin-like growth factor (IGF) binding protein-3 in human pregnancy serum with strongly reduced IGF-I binding

  2007cites this paper
• Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (IGFBP)-Related Protein 1 and the Related IGFBPL1 in Inhibiting Breast Cancer Phenotypes

  2007cites this paper
• In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer

  2007cites this paper
• Mechanisms of Kaposi sarcoma-associated herpesvirus induced tumorigenesis

  2007cites this paper
• Insulin-like growth factor-I receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: effect of IL-12 and IFN-gamma.

  2007cites this paper
• Effect of negative energy balance on the insulin-like growth factor system in pre-recruitment ovarian follicles of post partum dairy cows.

  2007cites this paper
• Insulin-like growth factor binding proteins and breast cancer

  2007cites this paper